Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182)
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
GARDASIL Reexamination Study (V501-059)
- Status
- COMPLETED
- Phase
- N/A
Re-examination Study For Varivax (V210-059 AM2)
- Status
- COMPLETED
- Phase
- N/A
Januvia Re-examination Study (MK-0431-181)
- Status
- COMPLETED
- Phase
- N/A
Raltegravir Treatment in Patients Failing Highly Active Antiretroviral Therapy (HAART) in Denmark
- Status
- COMPLETED
- Phase
- N/A
Early Airway Response to Allergen in Asthmatics (MK-0000-176)
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics of Suvorexant in Participants With Impaired Renal Function (MK-4305-023)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE1
Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016)
- Status
- COMPLETED
- Phase
- PHASE2
Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients
- Status
- COMPLETED
- Phase
- PHASE4
Rizatriptan 10 MG RPD in the Treatment of Acute Migraine
- Status
- COMPLETED
- Phase
- PHASE4
A Study That Will Evaluate Ketogenesis and Glucose-Dependent Insulin Secretion Methodologies in Healthy Male Subjects (MK-0000-159)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE1
Observational Study of Patients With Chronic Hepatitis C Virus (HCV) Infected With HCV Genotype 1 Low Virus Load (LVL 1) and Effect of PegIntron Plus Rebetol Treatment (Study P04793 Part 2)
- Status
- COMPLETED
- Phase
- N/A
Effects of Once and Twice Daily Dosing Regimen of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-040)
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of Sugammadex With Neostigmine as Reversal Agents for Rocuronium at Reappearance of T2 (Study P06101)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate [18F]-FDG PET (Fluorodeoxyglucose-positron) in Patients With Pancreatic Cancer (MK-0000-144)
- Status
- TERMINATED
- Phase
- PHASE1
Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)
- Status
- COMPLETED
- Phase
- N/A
A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASILâ„¢ (V503-006)
- Status
- COMPLETED
- Phase
- PHASE3
A Dose Escalation Study of Adavosertib(MK1775) in Combination With 5-FU or 5-FU/CDDP in Patients With Advanced Solid Tumor (1775-005
- Status
- TERMINATED
- Phase
- PHASE1
Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067)
- Status
- TERMINATED
- Phase
- PHASE2